Structural break signals
MED qualifies for the Red List on decline sigma.
The structural read
What price action says about MED.
MED qualifies for the Red List on decline sigma — the recent drop measures 1.5σ over a 10-bar window. Sigma scales the move by the stock's own typical daily volatility, so a small percentage drop in a normally-quiet name can land here when the bigger players miss it on a pure-percent threshold.
Cross-confirmation: also showing 5/5 bearish time frames.
Alongside that decline, our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames — moderate or strong time-frame-continuity (TFC) alignment — so the ticker also carries a Recovering badge. The two readings coexist: the tier tells you how deep the damage is, the Recovering badge tells you whether momentum may be turning. Recovering is not a buy signal; it's a structural read.
Upstream TFC read: strong alignment, current phase daily. Last bar types — daily 2D (green), weekly 1 (green), monthly 3 (green).
52-week range
Questions about MED
What people ask.
Why is MED on Broken Stocks?
MED qualifies for the Red List on decline sigma. The recent drop measures 1.5σ over a 10-bar window — large enough that even a small percentage drop is structurally significant given the stock's typical day-to-day volatility (5.28%). It additionally carries a Recovering badge — see below.
What does the Recovering badge mean for MED?
Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — MED is still Red List because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.
Is MED a falling knife?
MED is on Broken Stocks for time-frame continuity or decline-sigma reasons rather than headline depth, so the falling-knife label doesn't cleanly apply. The phrase usually requires a meaningful percentage drop from a fresh high. See the structural break signals above for the axis that actually triggered the listing.
Is MED a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is MED trading inside its 52-week range?
At $12.59, MED sits 80.0% of the way from its 52-week low ($9.22) to its 52-week high ($13.43). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.